Dr. Abhilasha Narayan

Dr. Abhilasha Narayan is an experienced Gynecologic Oncologist, Robotic Surgeon, and Laparoscopic Surgeon practicing at HCG Cancer Centre, Bengaluru. She specializes in the diagnosis and treatment of gynecological cancers with a special focus on cervical and ovarian cancers. Dr. Abhilasha is committed to delivering compassionate, patient-centered care by guiding and supporting patients throughout every stage of their cancer treatment.

She has received specialized training in gynecologic oncology and has extensive experience in minimally invasive cancer surgery, colposcopy, chemotherapy administration, and palliative cancer care. Her collaborative approach ensures personalized treatment plans designed to achieve the best possible clinical outcomes while maintaining quality of life.

Expertise

Dr. Abhilasha Narayan specializes in the comprehensive management of gynecological cancers using advanced surgical and medical treatment approaches.

• Cervical Cancer Treatment.
• Ovarian Cancer Treatment.
• Gynecologic Oncology Surgery.
• Robotic and Laparoscopic Cancer Surgery.
• Colposcopy and Cervical Screening.
• Preventive Gynecologic Oncology.
• Chemotherapy Administration.
• Palliative Cancer Care.

Training & Certifications

• Fellowship in Gynecologic Oncology – Kidwai Memorial Institute of Oncology, Bengaluru.

Awards & Recognition

• Young Gynecologic Oncologist Award for scientific paper presentation at the Annual Conference of the Association of Gynecologic Oncologists of India (AGOI), 2011.
• First Prize for paper presentation at the National Update on Cervical Cancer (2011).
• Presented numerous scientific papers at national and international conferences.
• Author and co-author of several research papers and case reports published in reputed national and international medical journals.

Research & Publications

Dr. Abhilasha has contributed to gynecologic oncology research through several publications in peer-reviewed national and international journals. Her work focuses on rare gynecological malignancies, ovarian cancers, fallopian tube cancers, and endometrial tumors, reflecting her commitment to advancing cancer diagnosis and treatment through evidence-based research.